Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors

Neurogastroenterology and Motility

Volumn 22, Issue 6, 2010, Pages

  Amato, A ^a   Cinci, L ^b   Rotondo, A ^a   Serio, R ^a   Faussone Pellegrini, M S ^b   Vannucchi, M G ^b   Mule F ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acetylcholine; Colon; Duodenum; Enteric nervous system; GI hormones; Immunohistochemis try; Nitric oxide

Indexed keywords

CARBACHOL; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GUANETHIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC TRANSMISSION; COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DUODENUM; EVOKED MUSCLE RESPONSE; IMMUNOHISTOCHEMISTRY; INTESTINE INNERVATION; INTESTINE MUSCLE; MALE; MOUSE; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOOTH MUSCLE CONTRACTION;

ACETYLCHOLINESTERASE; ANIMALS; ENTERIC NERVOUS SYSTEM; ENZYME INHIBITORS; GASTROINTESTINAL MOTILITY; GLUCAGON-LIKE PEPTIDE 1; GUANETHIDINE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MOTOR NEURONS; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; NITROARGININE; PEPTIDE FRAGMENTS; PERIPHERAL NERVOUS SYSTEM; RECEPTORS, GLUCAGON; SYMPATHOLYTICS;

EID: 77952109949     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01476.x     Document Type: Article

References (40)

1. Eissele R, Göke R, Willemer S et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 1992 22 : 283 291.
2. Theodorakis MJ, Carlson O, Michopoulos S et al. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am Physiol Endocrinol Metab 2006 290 : E550 9. (Pubitemid 43671703)
3. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007 132 : 2131 2157.
4. Sinclair EM, Drucker DJ. Proglucagon-derived peptides: mechanisms of action and therapeutic potential. Physiology 2005 20 : 357 365. (Pubitemid 41457401)
5. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998 101 : 515 520. (Pubitemid 28084232)
6. Gutzwiller JP, Göke B, Drewe J et al. Glucagon-like peptide-1: A potent regulator of food intake in humans. Gut 1999 44 : 81 6. (Pubitemid 29143284)
7. Giralt M, Vergara P. Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat. Dig Dis Sci 1999 44 : 322 329. (Pubitemid 29093556)
8. Bozkurt A, Näslund E, Holst JJ, Hellström PM. GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. Regul Pept 2002 107 : 129 135. (Pubitemid 34876454)
9. Giralt M, Vergara P. Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat. Regul Pept 1998 74 : 19 25. (Pubitemid 28234171)
10. Hellström PM, Näslund E, Edholm T et al. GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil 2008 20 : 649 659. (Pubitemid 351678618)
11. Imeryüz N, Yèen BC, Bozkurt A, Coşkun T, Villanueva-Peñacarrillo ML, Ulusoy NB. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol Gastrointest Liver Physiol 1997 273 : G920 7.
12. McDonagh SC, Lee J, Izzo A, Brubaker PL. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine. Am J Physiol Gastrointest Liver Physiol 2007 293 : G461 8. (Pubitemid 47263190)
13. Miki T, Minami K, Shinozaki H et al. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 2005 54 : 1056 1063. (Pubitemid 40446319)
14. Näslund E, Bogefors J, Skogar S et al. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol Regul Integr Comp Physiol 1999 277 : R910 6. (Pubitemid 29458166)
15. Schirra J, Houck P, Wank U, Arnold R, Göke B, Katschinski M. Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans. Gut 2000 46 : 622 631. (Pubitemid 30305778)
16. Schirra J, Nicolaus M, Roggel R et al. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut 2006 55 : 243 251. (Pubitemid 43117285)
17. Wettergren A, Wøjdemann M, Holst JJ. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol Gastrointest Liver Physiol 1998 275 : G984 92. (Pubitemid 28538952)
18. Gülpinar MA, Bozkurt A, Coşkun T, Ulusoy NB, Yegen BC. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats. Am J Physiol Gastrointest Liver Physiol 2000 278 : G924 9. (Pubitemid 30439171)
19. Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 1998 102 : 764 774. (Pubitemid 28399609)
20. Bullock BP, Heller RS, Habener JF. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 1996 137 : 2968 2978. (Pubitemid 26192194)
21. Campos RV, Lee YC, Drucker DJ. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 1994 134 : 2156 2164.
22. Nakagawa A, Satake H, Nakabayashi H et al. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci 2004 110 : 36 43. (Pubitemid 38180536)
23. Mulè F, Baffi MC, Cerra MC. Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon. Br J Pharmacol 2002 136 : 367 374. (Pubitemid 34620517)
24. Mulè F, Postorino A, Geraci A, Serio R. Neurotensin: Dual effect on the motor activity of rat duodenum. Eur J Pharmacol 1992 212 : 215 224.
25. Schemann M, Sann H, Schaff C, Mäder M. Identification of cholinergic neurons in enteric nervous system by antibodies against choline acetyltransferase. Am J Physiol 1993 265 : G1005 9. (Pubitemid 2015805)
26. Nagell CF, Wettergren A, Ørskov C, Holst JJ. Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs. Scand J Gastroenterol 2006 41 : 667 672. (Pubitemid 43995007)
27. Schirra J, Nicolaus M, Woerle HJ, Struckmeier C, Katschinski M, Göke B. GLP-1 regulates gastroduodenal motility involving cholinergic pathways. Neurogastroenterol Motil 2009 21 : 609 618.
28. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993 38 : 665 673. (Pubitemid 23121274)
29. Baggio LL, Huang Q, Brown TJ, Drucker DJ. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes 2004 53 : 2492 2500. (Pubitemid 39145610)
30. Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellström PM. Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: Effect mediated through central or enteric nervous mechanisms. Dig Dis Sci 1998 43 : 2284 2290. (Pubitemid 28487260)
31. Ayachi SE, Borie F, Magous R et al. Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39). Neurogastroenterol Motil 2005 17 : 302 309. (Pubitemid 40476692)
32. Brubaker PL, Drucker DJ, Asa SL, Swallow C, Redston M, Greenberg GR. Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor. J Clin Endocrinol Metab 2002 87 : 3078 3083. (Pubitemid 34816348)
33. Byrne MM, McGregor GP, Barth P, Rothmund M, Göke B, Arnold R. Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma. Digestion 2001 63 : 61 8. (Pubitemid 32098461)
34. Daniel EE, Anvari M, Fox-Threlkeld JE, McDonald TJ. Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum. Am J Physiol Gastrointest Liver Physiol 2002 283 : G595 602. (Pubitemid 34920346)
35. Andrews CN, Bharucha AE, Camilleri M et al. Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults. Am J Physiol Gastrointest Liver Physiol 2007 292 : G1359 65. (Pubitemid 47084663)
36. Näslund E, Skogar S, Efendic S, Hellström PM. Glucagon-like peptide-1 analogue LY315902: Effect on intestinal motility and release of insulin and somatostatin. Regul Pept 2002 106 : 89 95.
37. Kilbinger H. Modulation of acetylcholine release by nitric oxide. Prog Brain Res 1996 109 : 219 224. (Pubitemid 27047091)
38. Mang CF, Truempler S, Erbelding D, Kilbinger H. Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice. Am J Physiol Gastrointest Liver Physiol 2002 283 : G1132 8. (Pubitemid 35192850)
39. Bucinskaite V, Tolessa T, Pedersen J et al. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol Motil 2009 21 : 978 e78.
40. Amato A, Serio R, Mulè F. Peripheral motor effects of glucagon-like peptide 1 in mouse intestine. Neurogastroenterol Motil 2008 20 (Suppl. 2 111.